Fintech PR

Legal Barriers Falling for the Cannabis Market’s Rampant Growth

Published

5 years ago

April 9, 2019

Newsfile

Reading Time: 6 minutes

The cannabis market has begun to garner worldwide attention as more countries move to adopt cannabis legislation. Primarily, most countries are looking to adopt medical cannabis laws. Countries that have adopted medical legislation are leveraging cannabis to treat certain medical applications such as cancer, chronic pain, epilepsy, Alzheimer’s, and Parkinson’s disease. Throughout the past year, the cannabis industry has made significant milestones as the U.S. Food and Drug Administration approved its first cannabis-derived drug to treat epilepsy in children. Shortly after, the U.S. Drug Enforcement Agency removed CBD, or cannabidiol, off the Schedule 1 list. CBD-based products that have less than 0.1% THC concentrate will now be considered a Schedule 5 drug, as long as the medication has been approved by the FDA. Furthermore, the FDA recently scheduled a public hearing to be held in May as the agency looks to legalize CBD in food and drinks. The combination of these events has led to the exponential growth of the overall cannabis market. Moreover, as legalization efforts continue, other countries are expected to be influenced and potentially follow in legalizing cannabis. According to data compiled by Grand View Research, the global legal marijuana market was valued at USD 9.3 Billion and is expected to reach USD 146.4 Billion by the end of 2025. Additionally, the market is projected to register a CAGR of 34.6%. CLS Holdings, USA Inc. (OTC: CLSH) (CSE: CLSH.U), Charlotte’s Web Holdings, Inc. (OTC: CWBHF) (CSE: CWEB), Cresco Labs Inc. (OTC: CRLBF) (CSE: CL), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT)

Research and studies conducted within the cannabis industry have helped in adding credibility to the plant. However, the FDA ruled that due to the lack of large-scale and efficient clinical trials, the agency cannot approve cannabis as a registered treatment, yet. Now, researchers and companies involved within the industry are expanding their studies to help expand the cannabis market further. The FDA’s concern over cannabis becoming a legitimate medicine alternative signals the steps the market has taken. Decades ago, cannabis was internationally illegal. Now, countries including Australia, Canada, Columbia, Germany, the Netherlands, Spain, and the U.S. have all adopted cannabis legislation of some form. Moving forward, as more governments and regulatory agencies focus on the topic of cannabis legalization, the cannabis industry can become the next emerging global market. “It’s critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA’s regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods,” outgoing FDA Commissioner Scott Gottlieb recently said in a statement.

CLS Holdings, USA Inc. (OTCQB: CLSH) (CSE: CLSH.U) is also listed on the Canadian Securities Exchange under the ticker (CSE: CLSH.U). Earlier last week, the Company announced that, “since acquiring Oasis Cannabis Dispensary in Las Vegas, Nevada, CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH.U) has been working to elevate the entire customer experience behind cannabis. The catchphrase “New Oasis, Same Faces” assures customers that they will still receive the same care and attention they’ve come to expect from Oasis Cannabis, only now in a totally redesigned, modern, and fresh facility. The new space is more accessible, inviting and vibrant, with the same friendly and knowledgeable staff. Over the past few months, walls have been torn down and the color scheme have been modernized from lime green to bright white with blue accents, evoking a vibrant and calming feel. LED lit display cases are purposefully and openly situated, allowing customers ample room to explore products. The large white bud bar hosts the budtender, who is able to curate a better user experience through education and a diverse product selection. At the heart of the renovation is improving customer experience – but the company’s dedication to education, compassionate care, and community enrichment remain the same.

All are welcome to join the Oasis Cannabis Grand Reopening Party, which will take place at the dispensary on Saturday April 6th 2019 from 12:00pm – 10:00pm. The event will feature vendors on-site, live art, live music, food trucks, and special prices. The dispensary is located at 1800 Industrial Rd #180, Las Vegas, NV 89102.

About Oasis Cannabis: Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named “Best Dispensary for Pot Pros” by Desert Companion Magazine.

In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products. http://oasiscannabis.com

About City Trees: Founded in 2017, City Trees is a Nevada based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees is one the fastest growing wholesale companies in the industry. Its products are now available at 40 dispensaries. https://citytrees.com

About CLS Holdings USA, Inc: CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states. CLS stands for “Cannabis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.”

For our latest “Buzz on the Street” Show featuring CLS Holdings, USA Inc. recent corporate news, please head over to:

Charlotte’s Web Holdings, Inc. (OTCQX: CWBHF) (CSE: CWEB) is the market leader in the production and distribution of innovative hemp-based cannabidiol wellness products. Recently, Charlotte’s Web Holdings, Inc. surpassed 3,000 retail locations across the United States. At the end of 2017, Charlotte’s Web products were sold in approximately 2,000 locations. The Company had recently that it surpassed its 2018 year-end goal of 3,000 locations during the 3rd quarter. With CBD gaining mainstream market momentum, Charlotte’s Web, the industry pioneer and category leader in hemp-based CBD, has expanded its suite of product offerings across a wider variety of retailers, from small specialty health food stores to now including regional pharmacy and grocery chains. “Firstly, I would like to commend our incredible and committed staff who worked tirelessly to achieve this milestone,” stated Charlotte’s Web Chief Executive Officer Hess Moallem. “I would also like to thank our dedicated retail partners for their continued support of our mission and for valuing the trust that is closely associated with our brand name.”

Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) and CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) recently announced that they have entered into a definitive agreement, pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Origin House. Under the terms of the Agreement, holders of common shares of Origin House will receive 0.8428 subordinate voting shares of Cresco Labs for each Origin House Share. Origin House has become a leading distributor and provider of brand support services in California, the world’s largest regulated cannabis market. Origin House’s proven strategy has been to build relationships with established dispensaries, build partnerships with established market-leading brands, develop promising cannabis product companies, and then leverage its full suite of support services to transform those products into strong California consumer brands. Origin House delivers over 50+ cannabis brands to more than 500 dispensaries in California, representing approximately 60% market penetration. “The acquisition of Origin House is another example of our focused and disciplined approach to creating a meaningful presence in key cannabis markets through excellence in brand development and distribution,” said Cresco Labs Chief Executive Officer and Co-founder Charlie Bachtell.

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals, Inc. recently announced that it has initiated the Phase 2 BRIGHT (An Open-Label Tolerability and Efficacy Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Autism Spectrum Disorder) trial. The trial will assess the safety, tolerability and efficacy of Zygel (previously referred to as ZYN002) for the treatment of child and adolescent patients with Autism Spectrum Disorder (ASD). The Company expects to present topline data from this study in the first half of 2020. Clinical and anecdotal data suggest that CBD may modulate the EC system and improve certain core social and behavioral autism-related symptoms, including social avoidance and anxiety. “Autism spectrum disorder can have a devastating impact on a child and their family,” said Armando Anido, Chairman and Chief Executive Officer of Zynerba. “The medical need is significant and unmet despite high awareness and advocacy efforts. Though there has been an accelerating rate of diagnosis, to date there are only two FDA approved products indicated for the treatment of ASD symptoms.”

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) specializes in the extraction, purification and formulation of health and wellness products. Neptune Wellness Solutions Inc. recently announced that it had completed its initial commercial production lots and is now shipping cannabis extracts from its licensed, GPP facility in Sherbrooke, Quebec. “The quality of the extracts in Neptune’s first production runs at our state-of-the-art facility has been terrific, and we are proud to begin deliveries. This marks an important step forward in the execution of our vision to lever our decades of extraction and wellness industry experience towards becoming the world’s leader in the extraction, purification and formulation of value-added, differentiated cannabis products,” said Jim Hamilton, President and Chief Executive Officer of Neptune.

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

SOURCE FinancialBuzz.com

Fintech PR

FP Markets Awarded Best Forex Trading Tools 2023 by FXScouts

Published

1 hour ago

December 4, 2023

CISION (PR Newswire)

fp-markets-awarded-best-forex-trading-tools-2023-by-fxscouts

SYDNEY, Dec. 4, 2023 /PRNewswire/ — FP Markets has again been recognised for its outstanding trading solutions, receiving the Best Forex Trading Tools 2023 award from FXScouts. This accolade complements the company’s growing list of awards received this year, including ‘Best Trade Execution’ and ‘Most Transparent Broker’ at the Ultimate Fintech Awards APAC 2023. These prestigious awards further establish FP Markets as a leading broker dedicated to providing clients with the best possible trading experience. The company’s dedication to innovation is evident in its cutting-edge Trading Tools, which deliver a wide selection of features to assist traders and investors in navigating global financial markets more efficiently.

Founded in 2019, FxScouts.com is a well-known and respected organisation that helps traders discover top-rated Forex brokers. Boasting a global presence renowned for its rigorous and unbiased evaluation process, the company has independently tested and reviewed nearly 200 brokers and published wide-reaching Forex broker reviews.

Clients can access various Trading Tools with FP Markets, including Trading Central and Autochartist. Both are globally recognised powerhouses that deliver automated analytics. Additionally, traders can access a comprehensive Trader Toolbox for MT4 and MT5, a Trading Calculator designed with the trader in mind, and a suite of Trading Platforms, including MT4, MT5 and cTrader.

FP Markets Head of Content and Education, Aaron Hill, expressed his thoughts on the recent award, commenting: ‘This award recognises and highlights that the trader and investor’s needs come first at FP Markets, and the team are proud to have been acknowledged for their efforts. The ability to select from a wide range of trading tools to analyse and trade financial markets confidently and effectively is crucial for many traders and investors today. Gone are the days of sorting through charts to identify trading opportunities and manually calculating position size, margin and swap, for example. With FP Markets, you can employ easy-to-use Trading Tools to help streamline your trading process’.

Established in 2005, FP Markets is a Multi-Regulated Brand providing clients with over 10,000 tradable instruments across key asset classes and offers aggregate pricing across several top-tier liquidity providers. Additionally, FP Markets deliver Consistently Tight Spreads, Lightning Execution, Unmatched 24/7 Multilingual Customer Support, and various Account Types to suit all trading strategies and styles.

About FP Markets:

FP Markets is a Multi-Regulated Forex and CFDs Broker with over 18 years of industry experience.
The company offers highly competitive interbank Forex spreads starting from 0.0 pips.
Traders can choose from the leading powerful online trading platforms, including FP Markets’ Mobile App, MetaTrader 4, MetaTrader 5, WebTrader, cTrader, and Iress.
The company’s outstanding 24/7 multilingual customer service has been recognised by Investment Trends and awarded ‘The Highest Overall Client Satisfaction Award’ over five consecutive years.
FP Markets has been awarded the ‘Best Global Forex Value Broker’ for five consecutive years (2019, 2020, 2021, 2022, 2023) at the Global Forex Awards.
FP Markets has been awarded the ‘Best Forex Broker – Europe‘ and the ‘Best Forex Partners Programme – Asia‘ at the Global Forex Awards 2022 and 2023.
FP Markets has been awarded ‘Best Trade Execution’ at the Ultimate Fintech Awards 2022.
FP Markets crowned ‘Best CFD Broker in Africa‘ at FAME Awards 2023.

FP Markets Awarded ‘Best Trade Execution’ and ‘Most Transparent Broker’ at the Ultimate Fintech Awards APAC 2023

For more information on FP Markets’ comprehensive range of products and services, visit https://www.fpmarkets.com/.

Photo – https://mma.prnewswire.com/media/2292567/Best_Forex_Trading_Tools_Awards.jpg
Logo – https://mma.prnewswire.com/media/1574261/4438205/FP_Markets_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/fp-markets-awarded-best-forex-trading-tools-2023-by-fxscouts-302005151.html

Fintech PR

Banco Safra Files Lawsuit to Prevent Americanas and Its Controlling Shareholders from Moving Forward with Deficient Restructuring Plan

Published

2 hours ago

December 4, 2023

CISION (PR Newswire)

SAO PAULO, Dec. 4, 2023 /PRNewswire/ — Banco Safra today filed suit to prevent Americanas (the “Company”) and its controlling shareholders from moving forward with a deficient recovery plan that it believes would be nullified by the Judiciary.

Americanas and its controlling shareholders, Lemann, Telles and Sicupira, have proposed a recovery plan that seeks to prevent creditors from continuing to investigate the true causes of the fraud perpetrated at the Company. Banco Safra believes this clause is an illegal effort by the Company and its controlling shareholders to avoid accountability for the fraud and are challenging the legality of the recovery plan.

In January 2023, Americanas named Sérgio Rial as Chief Executive Officer. Rial was new to Americanas. Less than 10 days into his new role, he uncovered what he and others believed to be a massive fraud multiple times larger than the company’s net equity, resulting in the company filing for insolvency protection. Lemann, Telles and Sicupira claim that they, like the Company’s creditors, are victims of the fraud and have asserted that they were not aware of any wrongdoing at the company. They have made this claim even though they and their children sat on the Board of Directors of Americanas and have been overseeing the company and working with the executives who allegedly perpetrated the fraud for over 20 years.

To substantiate this assertion, the Board of Directors of Americanas handpicked an “Independent Committee” to investigate the alleged fraud. This Committee reports to the very same Board that oversaw the Company when the fraud was committed and has the contradictory mandate of investigating the same individuals who appointed it. This is a blatant conflict of interest and incongruent with basic corporate governance standards.

The Company and the controlling shareholders have now presented a new recovery plan that would result in creditors being repaid a fraction of what they are contractually owed on a commitment not to litigate or investigate against the controlling shareholders and their families and other directors of Americanas.

The controlling shareholders have the financial resources to fully repay creditors for all funds lost. Instead, as part of the recovery plan, they have proposed a capital injection that amounts to less than one third of the total value of the fraud and an insignificant amount in relation to their assets. In a coercive attempt to avoid fulfilling their obligations, creditors must agree to end the investigations into the fraud to benefit from this capital injection.

This illegal clause is just one of multiple deficiencies Banco Safra believes should nullify the entire Americanas recovery plan as set forth in the suit we filed today.

Media Contact
Robert Siegfried / Ross Lovern
Kekst CNC
212-521-4800

View original content:https://www.prnewswire.co.uk/news-releases/banco-safra-files-lawsuit-to-prevent-americanas-and-its-controlling-shareholders-from-moving-forward-with-deficient-restructuring-plan-302005020.html

Fintech PR

Collagen Gummy Sales Propelled by Convenience, Taste, and Health Benefits to Reach US$378 Million by 2033 | Future Market Insights, Inc.

Published

3 hours ago

December 4, 2023

CISION (PR Newswire)

collagen-gummy-sales-propelled-by-convenience,-taste,-and-health-benefits-to-reach-us$378-million-by-2033-|-future-market-insights,-inc.

NEWARK, Del., Dec. 4, 2023 /PRNewswire/ — A study by FMI attributes the flourishing global collagen gummy market to rising consumer awareness of the convenience, palatability, and health benefits of collagen gummies. Key players are actively engaging in mergers and collaborations to develop innovative products and maintain their market dominance, ensuring a dynamic and competitive landscape.

Explore further to gain comprehensive insights into the global collagen gummy market.

A Detailed Analysis of the Collagen Gummy Market by Berry and Citrus Flavors, from 2023 to 2033

The global collagen gummy market value is projected to reach US$ 247 million in 2023 and US$ 378 million by 2033. Over the forecast period, global demand for collagen gummies is anticipated to surge at 4.3% CAGR.

Get an Exclusive Sample Copy of the Collagen Gummies Market, 2023-2033: https://www.futuremarketinsights.com/reports/sample/REP-GB-18539

Several factors are expected to stimulate the growth of the collagen gummy market during the forecast period. These include growing awareness about the convenience, palatability, and health benefits of collagen gummies, rising health awareness, and easy availability through online platforms.

People worldwide are becoming aware about the health and cosmetic advantages of collagen supplement intake. As a result, demand for collagen gummies is rising significantly, and the trend is expected to continue through 2033.

Collagen gummies are believed to positively impact skin health, hair growth, joint health, and wound healing. This prompts people to consume these health supplements, bolstering their sales.

Rising health and wellness trends and interest in nutricosmetics will further boost the global collagen gummy industry. Similarly, new product launches and expanding e-commerce are expected to create growth prospects for collagen gummy companies.

Key companies are focusing on using celebrity endorsements to reach a wider audience and boost their sales. This will bode well for the target market.

Key Takeaways from the Global Collagen Gummy Market Study Report

The global collagen gummy market is set to total US$ 378 million in 2033.
By flavor type, the berry segment is projected to hold a value share of 34% in 2023.
Based on functionality, promoting skin health segment will likely account for about 25% of market share in 2023.

Understand global, regional, and country-level parameters with growth opportunities, historical data (2018-2022), and forecasts (2023-2033). Buy this report today!

Demand for collagen gummies in India is anticipated to rise at a CAGR of 6.2%.
The United States holds around 30.8% of the global market share.
Sales of collagen gummies in the United Kingdom are predicted to increase at 5.6% CAGR through 2033.
China is poised to exhibit a CAGR of 6.1% from 2023 to 2033.

“The global market for collagen gummies is expected to witness steady growth amid rising awareness about the benefits of collagen. Widespread advertising of processed collagen supplements by the manufacturers can be instrumental in boosting the popularity of collagen gummies in the low-income group countries,” says Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.).

Who is Winning?

The global collagen gummy market is highly consolidated, with most of suppliers concentrated in North America and Europe. However, the unavailability of sufficient sources of collagen in these regions is gradually shifting the business to Asian and African countries. This, in turn, has encouraged several regional collagen processing industries to enter the collagen gummy sector, which could diversify the market gradually.

Key players are adopting a wide variety of strategies to boost their sales and expand their global footprint. These include new product launches, mergers, celebrity endorsements, acquisitions, partnerships, and collaborations.

Recent Developments in the Collagen Gummy Industry:

In June 2020, Novomins Nutrition Inc. introduced its new product line of collagen gummies for its consumers. The company claims that the gummies contain hyaluronic acid, biotin, and vitamin C and are devoid of gluten and GMOs, artificial coloring, or sweeteners.
In November 2020, a new startup was established as the first cell-based collagen and Gelatin Company named Jellatech. The company was founded by Stephanie Michelsen and Kylie van Deinsen-Hesp, who claim to make gelatin and collagen using cellular agriculture and without animal products.

Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.

Get More Valuable Insights

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global collagen gummy market presenting historical demand data (2018 to 2022) and forecast statistics for the period from 2023 to 2033.

The study incorporates compelling insights on the collagen gummy industry based on flavor type, source, functionality, and sales channel across several regions.

About the Food and Beverage Division at Future Market Insights (FMI)

Expert analysis, actionable insights, and strategic recommendations – the food and beverages team at Future Market Insights (FMI) helps clients from all over the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the food and beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

About the Author:

Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.) has 7+ years of management consulting experience. She advises industry leaders and explores off-the-eye opportunities and challenges. She puts processes and operating models in place to support their business objectives.

She has exceptional analytical skills and often brings thought leadership to the table.

Nandini has vast functional expertise in key niches, including but not limited to food ingredients, nutrition & health solutions, animal nutrition, and marine nutrients. She is also well-versed in the pharmaceuticals, biotechnology, retail, and chemical sectors, where she advises market participants to develop methodologies and strategies that deliver results.

Her core expertise lies in corporate growth strategy, sales and marketing effectiveness, acquisitions and post-merger integration and cost reduction. Nandini has an MBA in Finance from MIT School of Business. She also holds a Bachelor’s Degree in Electrical Engineering from Nagpur University, India.

Nandini has authored several publications, and quoted in journals including Beverage Industry, Bloomberg, and Wine Industry Advisor.

Explore FMI’s Extensive Coverage in the Food and Beverages Domain:

Sugar-Free Sweets Market to Reach US$3.9 Billion by 2033, Driven by Health Consciousness and Rising Demand for Alternative Sweeteners. – Get a Sample Report Copy.
Driven by growing demand for health and wellness products, the collagen peptide market is projected to reach US$1.23 billion by 2033. – Get a Sample Report Copy.
Global collagen supplement market is projected to expand at a compound annual growth rate (CAGR) of 6.4% reaching a valuation of US$ 2.8 billion by 2032. – Get a Sample Report Copy.
The sugar-free gummy market is projected to reach a valuation of US$1,040 million by 2033, expanding at a CAGR of 5.2% from an estimated US$627 million in 2023. – Get a Sample Report Copy.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI’s latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition.

Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube